TSR2 Inhibitors

TSR2 inhibitors encompass a variety of compounds that exert their inhibitory effect by targeting processes critical for ribosomal function and protein synthesis, both of which are essential for TSR2's role in ribosome maturation. For instance, compounds that inhibit the translocation step in protein synthesis or the initial elongation step of translation directly hinder the production of proteins, which subsequently reduces the functional need for TSR2's ribosome maturation activity. Similarly, by binding to and inhibiting key transcriptional and translational machinery, such as RNA polymerase II and the mechanistic target of rapamycin (mTOR), these inhibitors cause a decrease in ribosome biogenesis, consequently diminishing the role of TSR2. Furthermore, the inhibition of N-linked glycosylation affects protein stability and function in the endoplasmic reticulum, indirectly impairing TSR2's associated processes.

Additional inhibitors act by depleting essential nucleotides or by damaging components of the ribosome itself, which indirectly decreases TSR2 activity due to a lesser demand for ribosome maturation. Inhibitors that prevent the formation of guanosine nucleotides or remove specific adenine residues from ribosomal RNA compromise ribosome function and assembly, reducing the requirement for TSR2's maturation function. Inhibitors that bind to ribosomal subunits to prevent peptide bond formation or the initiation of translation further decrease the need for mature ribosomes, ultimately leading to a reduction in TSR2's involvement in ribosome biogenesis.